Position in BIIB
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$327,726,504
+$182,744,192 QoQ
Shares Held
1,516,831
+91.8% QoQ
Ownership
1.03%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#14
of 1,037 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Amundi holds $20,539,050,875 across 14 Drug Manufacturers - General names. BIIB ranks #10 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,808,143 | $5,767,031,432 | |
| 2 | JNJ |
Johnson & Johnson
|
13,117,657 | $3,331,491,343 | |
| 3 | AZN |
Astrazeneca PLC
|
16,422,784 | $3,114,088,296 | |
| 4 | ABBV |
AbbVie Inc.
|
10,039,289 | $2,526,286,678 | |
| 5 | MRK |
Merck & Co., Inc.
|
12,342,274 | $1,585,982,207 | |
| 6 | AMGN |
Amgen Inc
|
3,890,189 | $1,408,715,236 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
9,772,438 | $1,234,649,812 | |
| 8 | PFE |
Pfizer Inc
|
33,533,616 | $807,489,467 |
All Filings in BIIB
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $327,726,504 | 1,516,831 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $144,982,312 | 790,827 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $100,741,778 | 572,429 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $86,612,723 | 618,309 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $72,816,704 | 579,797 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $180,074,181 | 1,315,947 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $186,102,102 | 1,216,990 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $173,973,720 | 897,512 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $158,754,968 | 684,820 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $212,568,479 | 985,802 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $310,965,455 | 1,201,706 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $281,046,596 | 1,093,524 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $338,206,100 | 1,187,313 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $160,782,797 | 578,293 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $226,695,844 | 818,633 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $173,255,232 | 648,896 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $83,173,863 | 407,835 | Shares | Defined | 2022-09-02 | |
| 2022-03-31 | $73,132,110 | 347,256 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $192,798,263 | 803,594 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $241,957,295 | 855,003 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $214,582,818 | 619,698 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||